Actimis Pharmaceuticals

About:

Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.

Website: http://www.actimis.com

Top Investors: Mitsui Global Investment, Sanderling Ventures

Description:

Actimis Pharmaceuticals, Inc., is a start-up biopharmaceutical company focused on the development of small molecule therapeutics for respiratory and inflammatory disorders. Actimis was created as a spin-off from the respiratory diseases therapeutic research portfolio of Bayer Healthcare AG. The spin-off was founded by Dr. Kevin Bacon and has received venture financing from a syndicate lead by Sanderling Ventures of San Mateo, California and Mitsui & Co Venture Partners of New York. Dr. Bacon was most recently Vice President and Global Head of Respiratory diseases research at Bayer Yakuhin Ltd., Japan where the programs were initiated.

Total Funding Amount:

$15.6M

Headquarters Location:

San Diego, California, United States

Founded Date:

2004-01-01

Founders:

Kevin B. Bacon

Number of Employees:

11-50

Last Funding Date:

2008-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai